Dr. Suissa has received consulting fees, speaking fees, and/or honoraria from Bristol-Myers Squibb and Schering-Plough (less than $10,000 each), and from Boehringer Ingelheim, Pfizer, Merck, and Bayer (more than $10,000 each).
Letters to the Editor
You have full text access to this OnlineOpen article
Have some beneficial effects of hydroxychloroquine been overestimated? Potential biases in observational studies of drug effects: Comment on the article by Pons-Estel et al
Article first published online: 29 OCT 2009
DOI: 10.1002/art.24895
Copyright © 2009 by the American College of Rheumatology
Additional Information
How to Cite
Vinet, E., Bernatsky, S. and Suissa, S. (2009), Have some beneficial effects of hydroxychloroquine been overestimated? Potential biases in observational studies of drug effects: Comment on the article by Pons-Estel et al. Arthritis & Rheumatism, 61: 1614–1615. doi: 10.1002/art.24895
Publication History
- Issue published online: 29 OCT 2009
- Article first published online: 29 OCT 2009
Cited in:
- CrossRef
This article has been cited by:
- 1, , , The role of antimalarial agents in the treatment of SLE and lupus nephritis, Nature Reviews Nephrology, 2011, 7, 12, 718

2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b)